Pharma's Progress In Precision Medicine

Precision medicine is significantly impacting pharma dealmaking, R&D and market access, according to a new report from Datamonitor Healthcare.

Precision medicine is about more than molecularly targeted treatments. It increasingly refers to a far broader notion of getting the right therapy to the right patient at the right time, using any one or more of a multitude of tools and technologies. It is about getting better data about patients’ conditions, needs and lifestyles in order to allow the most appropriate treatment, and, ultimately, effective prevention strategies.

Precision Medicine and The Future of Healthcare, a new report from Informa's Datamonitor Healthcare division, indicates...

More from Market Access

More from In Vivo